Glenmark Pharma gets USFDA nod for seizure treatment drug Posted By: Unknown January 24, 2019 Leave a Reply Shares of Glenmark Pharmaceuticals were trading 1.02% higher at Rs 656.10 apiece on the BSE from Latest News http://bit.ly/2TaCJvR https://ift.tt/eA8V8J http://bit.ly/2SdCH5P Tweet Share Share Share Share
0 comments: